share_log

Cartesian Therapeutics Q1 2024 GAAP EPS $(10.50) May Not Be Comparable To $(0.89) Estimate, Sales $5.840M May Not Be Comparable To $1.250M Estimate

Benzinga ·  May 8 07:22
Cartesian Therapeutics Q1 2024 GAAP EPS $(10.50) May Not Be Comparable To $(0.89) Estimate, Sales $5.840M May Not Be Comparable To $1.250M Estimate
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment